Annual Meeting 2022: Advancing Precision Immuno-oncology
“The immuno-oncology revolution is now about 15 years into clinical reality,” said Carl June, MD, FAACR, director of the...
Tag: Immuno-oncology
“The immuno-oncology revolution is now about 15 years into clinical reality,” said Carl June, MD, FAACR, director of the...
Cancer immunotherapy research has exploded in recent years. This treatment utilizes a patient’s own immune system to recognize and...
On September 6, 2018, the U.S. Food and Drug Administration (FDA) and the American Association for Cancer Research hosted...
The potential for developing new immunotherapies and expanding the use of existing ones will be the focus of the...
Myeloma is the third most common blood cancer in the United States, arising in the plasma cells of the...